查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1196945

全球乳房固定术市场——增长、趋势、COVID-19 的影响和预测 (2023-2028)

Global Mastopexy Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

所研究的乳房固定术市场预计在预测期内（2022 年至 2027 年）以 5.7% 的复合年增长率增长。

随着新型冠状病毒肺炎 (COVID-19) 大流行的发展，烧蚀换肤激光、微针和皮肤外科手术的安全性似乎也受到了损害。 此外，经济放缓和可自由支配支出的下降对顾客造成了真正的限制，因为他们迴避昂贵的美容治疗。 根据 2020 年整形外科统计报告，2020 年共有 87,051 名患者接受了乳房固定术。 因此，预计全球人口对美容手术的偏好将推动疫情期间的市场增长。

据估计，女性老年人口的增加和整容手术需求的增加将推动预测期内的市场增长。 不断上升的医疗成本和不断增长的门诊手术需求正在推动市场增长。 此外，增加产品发布也有望促进市场增长。 例如，2021年5月，GC Aesthetics Inc.推出了下一代乳房植入物“PERLE”。 PERLE 是高度创新的光滑乳房植入物系列，采用专有表面技术、GCA 行业领先的凝胶技术和增强的安全功能，巩固了 GCA 长期成功的安全记录。 2021 年 2 月，高德美 (Galderma) 获得美国食品药品监督管理局 (Food and Drug Administration) 批准 RESTYLANE DEFYNE 用于增强和矫正成人轻度至中度颌骨退缩。 然而，据估计，在预测期内，乳房固定术的高成本以及随后的手术并发症等因素将抑制市场增长。

乳房固定术市场趋势

预计在预测期内全乳房固定术将主导市场

就技术而言，完整的乳房固定术细分市场在收入方面占据了大部分市场份额。 完全性乳房固定术主要针对老年女性乳房下垂的情况进行。 它也适用于接受过乳房固定术或乳房切除术的乳腺癌患者。 在这种手术中，外科医生往往会去除癌组织，这可能会导致乳房重建手术。 据美国癌症协会估计，2022 年美国将诊断出 287,850 例浸润性乳腺癌新病例。 因此，乳腺癌的高发病率可能会推动市场增长。

Mastopexy 在有或没有植入物的情况下都能恢復胸部的体积和丰满度。 根据美学协会 2022 年 4 月发表的文章，2021 年乳房手术的年度统计数据与 2020 年相比增长了 48%。 2021 年进行了 365,000 次乳房植入手术。 因此，越来越多的乳房植入物将有助于在预测期内推动对全乳房固定术的需求。

预计在预测期内北美将呈现出众的增长

北美地区占 2021 年市场收入的大部分份额，预计在预测期内将继续如此。 推动该地区增长的因素包括女性对整容手术的需求不断增长以及可支配收入的增加。 根据美国骨科医师学会的数据，自 2000 年以来，随着正在开发的新的和富有想像力的塑造身体的方法，微创整容手术增加了近 200%。 丰胸手术在北美地区名列前茅。 乳腺癌是美国主要的癌症类型之一。 根据 2022 年 1 月更新的 Breastcancer.org，大约八分之一的女性（约 13%）将在其一生中患上浸润性乳腺癌。 预计这种女性乳腺癌发病率将推动市场增长。

在美国，女性对整容手术的需求非常高，这是该地区乳房固定术市场增长的关键因素之一。 例如，美国整形外科学院 2020 年 5 月的一份报告将隆胸列为 2020 年美国进行的前五名整容手术之一。 此外，2020 年实施的乳房植入物总数为 193,073 例。 预计北美乳腺癌患病率的增加也将补充该地区乳房固定术市场的增长。 根据 GLOBOCAN 2020 报告，2020 年美国、加拿大和墨西哥的乳腺癌新发病例数分别为 253,465 例、28,026 例和 29,929 例。 因此，预计在预测期内，北美将在乳房固定术市场中占据很大的市场份额。

Mastopexy 市场竞争对手分析

乳房固定术市场竞争适中，由几家大型企业组成。 目前主导市场的公司包括 Allergan、Sientra, Inc、Ideal Implant Incorporated、Johnson & Johnson、Establishment Labs、POLYTECH Health & Aesthetics GmbH、RTI Surgical, Inc、Groupe Sebin SAS、Integra LifeSciences 和 GC Aesthetics。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 越来越多地采用胸部提升术
    • 人们越来越倾向于强调外在美
    • 老年女性人口增加
    • 整容手术的上升趋势
  • 市场製约因素
    • 这些程序的高成本
    • 术后并发症
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按技术
    • 贝内利电梯
    • 新月形隆胸
    • Benelli Lollipop 升降机
    • 完整的乳房固定术
  • 通过使用
    • 专科诊所
    • 医院
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 意大利
      • 其他欧洲地区
    • 亚太地区
      • 印度
      • 日本
      • 中国
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Allergan
    • Mentor Word Wide LLC
    • GC Aesthetics
    • Lipoclastic
    • Cynosure
    • Polytech Health & Aesthetics
    • Sientra
    • Galderma
    • Lumenis
    • Solta Medical
    • Syneron Medical

第7章 市场机会今后动向

简介目录
Product Code: 91279

The Mastopexy market studied is expected to grow with an estimated CAGR of 5.7% over the forecast period (2022-2027).

As the COVID-19 pandemic progressed with new strains, the safety of ablative resurfacing lasers, micro-needling, and dermatological surgery procedures also seemed to be unsafe. Additionally, the slowing economy and reduced discretionary spending discourage customers from undergoing expensive cosmetic treatments, thus imposing practical restrictions. The Plastic Surgery Statistics Report from the year, 2020 states that a total population of 87,051 patients underwent mastopexy surgery in 2020. Therefore the preference for aesthetic surgeries among the global population is expected to drive the growth of the market during the pandemic period.

The rising female geriatric population and growing demands for aesthetic procedures are estimated to drive market growth during the forecast period. Increased healthcare expenditures and the growing demands for outpatient surgeries are boosting market growth. Additionally, the increasing product launches are expected to contribute to the growth of the market. For, Instance, In May 2021, GC Aesthetics Inc. launched its next generation of breast implants, PERLE. PERLE is a highly innovative line of smooth breast implants that features proprietary surface technology, GCA's industry-leading gel technology, and an enhanced version of the safety features that have underpinned GCA's long-term excellent safety record. In February 2021, Galderma received the approval of RESTYLANE DEFYNE by the United States Food and Drug Administration for the augmentation and correction of mild to moderate chin retrusion for adults. However, factors such as the high cost of mastopexy followed by complications of the surgery are estimated to restrain the market growth during the forecast period.

Mastopexy Market Trends

Full Mastopexy Segment is Expected to Dominate the Market over the Forecast Period

Based on technique, the full mastopexy segment held a majority of the market share in terms of revenue. The full mastopexy procedure is performed in cases of breast sagginess, mainly observed in older women. Mastopexy is also performed in breast cancer patients who undergo mastectomy and lumpectomy. During the procedure, the surgeons tend to remove cancerous tissues, which can lead to breast reconstruction surgery. According to the American Cancer Society, it was estimated that 287,850 new cases of invasive breast cancer would be diagnosed in the United States in 2022. The high incidence of breast cancer can thus boost market growth.

The mastopexy restores the volume and fullness of the breasts with or without the use of implants. As per the Aesthetic Society article published in April 2022, the annual statistics of breast surgical procedures in 2021, accounted for 48% growth compared to 2020. There were 365,000 breast augmentations performed in 2021. Thus, the increase in the number of breast augmentations will help to propel the demand for full mastopexy during the forecast period.

North America is projected to have a Prominent Growth Rate over the Forecast Period

North America region is the majority share contributor to the market revenue in 2021 and is expected to continue during the forecast period. Some of the factors driving regional growth include the rising demand for aesthetic procedures among women and increased disposable income. According to the American Society of Plastic Surgeons figures, new and imaginative ways to shape the bodies are been developed, with minimally invasive cosmetic operations increasing nearly 200 percent since 2000. Breast enhancement is one of the top cosmetic surgical procedures performed in the North American region. In the United States, breast cancer is one of the leading cancer types. According to Breastcancer.org, updated in January 2022, about 1 in 8 women (about 13%) will develop invasive breast cancer over their lifetime. Such prevalence of breast cancer among women is expected to drive the growth of the market.

The demand for cosmetic surgeries and procedures in the United States is very high among women, which is one of the significant factors for the growth of the mastopexy market in the region. For instance, according to the American Society of Plastic Surgeons report published in May 2020, breast augmentation was one of the top five cosmetic surgical procedures performed in 2020 in the United States. Moreover, the total number was 193,073 breast augmentation procedures in 2020. In addition, the increasing prevalence of breast cancer in North America will also complement the growth of the mastopexy market in the region. As per the GLOBOCAN 2020 report, the new breast cancer cases in the United States, Canada, and Mexico were 253,465, 28,026, and 29,929, respectively, in 2020. Therefore, North America is expected to hold a significant market share in the Mastopexy market during the forecast period.

Mastopexy Market Competitor Analysis

The mastopexy market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Allergan, Sientra, Inc,Ideal Implant Incorporated, Johnson & Johnson, Establishment Labs, POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., Groupe Sebin SAS, Integra LifeSciences, and GC Aesthetics.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definitions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing adoption of breast lifting procedures
    • 4.2.2 Growing prominence on physical appearance
    • 4.2.3 Rising female geriatric population
    • 4.2.4 Rising trend of aesthetic procedures
  • 4.3 Market Restraints
    • 4.3.1 High cost of these procedures
    • 4.3.2 Post-surgery complications
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Technique
    • 5.1.1 Benelli Lift
    • 5.1.2 Crescent Breast Lift
    • 5.1.3 Benelli-Lollipop Lift
    • 5.1.4 Full Mastopexy
  • 5.2 By End use
    • 5.2.1 Speciality Clinics
    • 5.2.2 Hospitals
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 United Kingdom
      • 5.3.2.2 Germany
      • 5.3.2.3 France
      • 5.3.2.4 Spain
      • 5.3.2.5 Italy
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 India
      • 5.3.3.2 Japan
      • 5.3.3.3 China
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of the Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan
    • 6.1.2 Mentor Word Wide LLC
    • 6.1.3 GC Aesthetics
    • 6.1.4 Lipoclastic
    • 6.1.5 Cynosure
    • 6.1.6 Polytech Health & Aesthetics
    • 6.1.7 Sientra
    • 6.1.8 Galderma
    • 6.1.9 Lumenis
    • 6.1.10 Solta Medical
    • 6.1.11 Syneron Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS